SANAA, July 6 (YPA) – Reports revealed that Britain is in the process of reaching an agreement worth 500 million pounds (624 million dollars) with Sanofi and GlaxoSmith to purchase 60 million doses of the vaccine that the two companies are developing against Corona.
The Sunday Times newspaper said on Sunday that Britain is considering the option of purchasing the vaccine if it is proven to be effective in human trials due to start next September.
British AstraZeneca, French Sanofi, American Pfizer and British GlaxoSmithKline are all in various stages of developing their candidate vaccines to combat Covid 19 disease caused by the coronavirus.
About a dozen Covid-19 vaccines are being tested in humans, and experts predict that it will take 12 to 18 months for a safe and effective vaccine to be produced.